Biofrontera AG

Biofrontera AG

B8F.DE
Biofrontera AGDE flagDeutsche Börse
6.80
EUR
+6.48
- -
20.67MMarket Cap

Biofrontera AG (B8F.DE) Stock Split History

Learn about Biofrontera AG's most recent 1-for-21 basis stock split on May 14, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Biofrontera AG's most recent stock split

Split Date: 2024-05-14
Split Ratio: 1:21
Price Before Split: $0.21
Price After Split: $0.01

Developer API

Get B8F.DE split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/B8F.DE

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 21.00 times fewer shares (a 1:21 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Biofrontera AG's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-05-141:21Yes$0.21$0.01
2022-10-28209:200No$737.35$705.60
2021-02-081027:1000No$1471.93$1433.23
2018-01-301049:1000No$2859.72$2726.14
2016-04-051011:1000No$1034.00$1022.75
2015-10-2843:42No$971.25$948.67
2012-03-081061:1000No$1488.50$1402.92

About Biofrontera AG

Company overview and industry information

Biofrontera AG (B8F.DE) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-21 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Drug Manufacturers - Specialty & Generic
Go to Biofrontera AG Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.